{"id":985,"date":"2025-02-17T22:38:22","date_gmt":"2025-02-17T19:38:22","guid":{"rendered":"https:\/\/patheconomics.com\/?p=985"},"modified":"2025-02-18T00:32:16","modified_gmt":"2025-02-17T21:32:16","slug":"hta-workshop","status":"publish","type":"post","link":"https:\/\/patheconomics.com\/ar\/hta-workshop\/","title":{"rendered":"Evidence Generation and Synthesis Methods in Health Technology Assessment (HTA) Workshop!"},"content":{"rendered":"

Event Details:<\/span><\/strong><\/span><\/p>\n

\"\"<\/p>\n

Saudi Arabia Concludes Landmark Health Technology Assessment (HTA) Workshop with Global Experts<\/span><\/strong>
\nDATE:<\/strong> \ud83d\udcc5 February 8-12, 2025<\/span>
\nLOCATION:<\/strong> \ud83d\udccd Riyadh, Saudi Arabia<\/span><\/p>\n

Saudi Arabia successfully hosted the Health Technology Assessment (HTA) Workshop<\/a><\/span><\/span> at Crowne Plaza Riyadh Palace from February 8 to 12, 2025, bringing together renowned global experts, policymakers, and researchers to advance evidence-based healthcare decision-making. The event, hosted by King Saud University in collaboration with the Saudi Food and Drug Authority (SFDA), NICE International, and EuroQol<\/strong>, provided a crucial platform for discussing health economics, patient-centered care, and innovative policy strategies<\/strong>.<\/span><\/p>\n

The workshop featured distinguished speakers from Saudi Arabia, the United Kingdom, the United States, Canada, the Netherlands, Egypt, Spain, and Qatar<\/strong>, representing organizations such as:<\/span><\/p>\n

\u2022 NICE International (UK)<\/span>
\n\u2022 EuroQol (Netherlands)<\/span>
\n\u2022 Saudi Food and Drug Authority (SFDA)<\/span>
\n\u2022 King Saud University (Saudi Arabia)<\/span>
\n\u2022 Path Economics, LLC (USA)<\/span>
\n\u2022 CCHO (UAE & Canada)<\/span>
\n\u2022 National Institute for Health and Care Excellence (NICE)<\/span>
\n\u2022 ISPOR Qatar Chapter<\/span><\/p>\n

Key Topics and Highlights:<\/span><\/strong>
\nOver five days, the workshop facilitated expert-led discussions, case studies, and real-world applications on critical areas, including:<\/span><\/p>\n

\u2714 Health Economics and Evidence-Based Decision-Making<\/strong> \u2013 Experts explored systematic reviews, meta-analysis techniques, and Cochrane risk assessments to strengthen healthcare evaluations.<\/span>
\n\u2714 Artificial Intelligence and Real-World Data (RWD)<\/strong> \u2013 Sessions examined AI-driven data analysis and big data applications in healthcare decision-making.<\/span>
\n\u2714 Patient-Centered Outcomes and the Saudi EQ-5D Value Set<\/strong> \u2013 Discussions focused on Patient-Reported Outcome Measures (PROMs) and their integration into healthcare policies, with a particular emphasis on the new EQ-5D Value Set for Saudi Arabia.<\/span>
\n\u2714 Economic Evaluations in Healthcare<\/strong> \u2013 Participants analyzed Quality-Adjusted Life Years (QALYs), Disability-Adjusted Life Years (DALYs), and ISPOR guidelines for economic modeling.<\/span>
\n\u2714 Budget Impact Model (BIM) Adaptation<\/strong> \u2013 A highlight of the event was the session led by Dr. Nimer Alkhatib, PhD, a globally recognized health economist and founder of Path Economics, LLC (USA). Dr. Alkhatib provided a step-by-step framework for adapting budget impact models in different disease areas, including oncology and diabetes, guiding policymakers on optimizing healthcare cost assessments.<\/span>
\n\u2714 Managed Entry Agreements (MEA) and Outcome-Based Pricing<\/strong> \u2013 Discussions, led by Dr. Steve Williamson, Dr. Pilar Pinilla-Dominguez, and Dr. Dalia Dawoud, examined innovative pricing strategies for orphan medications and rare disease treatments.<\/span><\/p>\n

Keynote Speakers and Moderators:<\/span><\/strong>
\nThe event featured a prestigious lineup of experts, including:<\/span><\/p>\n

Keynote Speakers:<\/span><\/strong>
\n\u2022 Dr. Nimer Alkhatib, PhD<\/a><\/span><\/strong> (Founder, Path Economics, LLC, USA)<\/span>
\n\u2022 Dr. Steve Williamson, PhD<\/strong> (Associate Director, NICE International, UK)<\/span>
\n\u2022 Dr. Pilar Pinilla-Dominguez, PhD<\/strong> (Associate Director, NICE International, Spain)<\/span>
\n\u2022 Dr. Dalia Dawoud, PhD<\/strong> (Associate Director, NICE, Egypt)<\/span>
\n\u2022 Dr. Richard Chapman, PhD<\/strong> (Chief Scientific Officer, Center of Innovation & Value Research, USA)<\/span>
\n\u2022 Dr. Fatima AlSayah, PhD<\/strong> (Principal & PROMs Lead, CCHO, Canada)<\/span>
\n\u2022 Dr. Elly Stolk, PhD<\/strong> (Scientific Director, EuroQol, Netherlands)<\/span>
\n\u2022 Dr. Randa Attieh, PhD<\/strong> (Scientific Counselor, INESS, Canada)<\/span>
\n\u2022 Dr. Howard Friedman, PhD<\/strong> (Chief Data Scientist, Columbia University, USA)<\/span><\/p>\n